Stacy Ann Coen, SVP & CHIEF BUSINESS OFFICER at ImmunoGen, Inc. (IMGN), sold 213,118 shares at $16.01 ($3.4M) on 2023-11-16, disclosed to the SEC on 2023-11-17.
Scheduled sale ($3.4M) by SVP & CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.01 | 26,286 | $421K | 12.3% |
| 2 | $16.01 | 26,286 | $421K | 12.3% |
| 3 | $16.01 | 4,100 | $66K | 1.9% |
| 4 | $16.05 | 78,223 | $1.3M | 36.7% |
| 5 | $16.05 | 78,223 | $1.3M | 36.7% |
| Total | $16.04 avg | 213,118 |
| $3.4M |
| 100% |
| Filing → |
| IMGN | SELL | 2023-08-11 | $1.4M | — | Filing → |
| IMGN | SELL | 2023-08-04 | $2.9M | — | Filing → |